OPB-31121

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameOPB-31121
Drug Alias NameOPB-31121
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsSolid tumoursMultiple MyelomaCarcinoma, Hepatocellular +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth KoreaHong Kong +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOtsuka Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Texas MD Anderson Cancer CenterOtsuka Pharmaceutical Co LtdKorea Otsuka Pharmaceutical Co Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsSolid tumoursMultiple MyelomaCarcinoma, Hepatocellular +[6] 

Other Information

ATC CodeN/A
Related LinksN/A